5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.24▲ | 7.22▲ | 7.23▲ | 7.50▼ | 7.39▼ |
MA10 | 7.22▲ | 7.24▲ | 7.23▲ | 7.62▼ | 6.36▲ |
MA20 | 7.21▲ | 7.28▼ | 7.32▼ | 7.25▲ | 8.18▼ |
MA50 | 7.37▼ | 7.58▼ | 7.69▼ | 6.14▲ | 15.31▼ |
MA100 | 7.65▼ | 7.80▼ | 7.68▼ | 9.81▼ | 16.76▼ |
MA200 | 7.84▼ | 7.25▲ | 6.73▲ | 15.38▼ | 54.88▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.019▲ | 0.022▲ | 0.011▲ | -0.075▼ | 0.374▲ |
RSI | 49.964▼ | 45.565▼ | 44.334▼ | 52.022▲ | 39.775▼ |
STOCH | 56.284 | 63.163 | 60.371 | 25.676 | 70.386 |
WILL %R | -27.869 | -27.869 | -39.726 | -78.310▼ | -30.318 |
CCI | 49.319 | 39.106 | 8.456 | -111.082▼ | 76.062 |
Thursday, June 12, 2025 05:00 PM
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best ...
|
Thursday, May 29, 2025 05:00 AM
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best ...
|
Tuesday, May 06, 2025 06:35 AM
Aligos Therapeutics, Inc. (ALGS) came out with a quarterly loss of $2.11 per share versus the Zacks Consensus Estimate of a loss of $2.80. This compares to loss of $5.50 per share a year ago.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/06/25 | 7.35 | 7.35 | 7.045 | 7.265 | 54,233 |
27/06/25 | 7.15 | 7.46 | 6.88 | 7.21 | 87,518 |
26/06/25 | 7.68 | 7.68 | 7.11 | 7.14 | 72,021 |
25/06/25 | 8.18 | 8.544 | 7.42 | 7.63 | 141,345 |
24/06/25 | 7.21 | 8.655 | 7.21 | 8.24 | 137,578 |
23/06/25 | 7.54 | 7.84 | 7.11 | 7.18 | 59,013 |
20/06/25 | 8.50 | 8.50 | 7.55 | 7.55 | 152,862 |
18/06/25 | 7.58 | 8.49 | 7.4284 | 8.37 | 111,049 |
17/06/25 | 8.00 | 8.06 | 7.5011 | 7.53 | 92,510 |
16/06/25 | 7.90 | 8.2775 | 7.78 | 8.05 | 66,495 |
|
|
||||
|
|
||||
|
|